Gts Securities LLC Axsome Therapeutics, Inc. Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$78.93 - $95.84 $189,432 - $230,016	-2,400 Reduced 16.33%	12,300 $1.11 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $1.01 Million - $1.24 Million	-15,400 Reduced 51.16%	14,700 $1.18 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $1.64 Million - $2.31 Million	23,700 Added 370.31%	30,100 $2.4 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $620,136 - $902,988	-10,800 Reduced 62.79%	6,400 $509,000
Q3 2023 Nov 15, 2023	BUY	$69.25 - $82.21 $1.19 Million - $1.41 Million	17,200 New	17,200 $1.2 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.27B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.